Clinical Trial Update: Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing semaglutide injection to Ozempic in adults with Type 2 diabetes, focusing on efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)
• semaglutide (semaglutide)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED